AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

NEUROTECH INTERNATIONAL LTD

0.027

+0.000

Volume:1.60M

Turnover:44.28K

Market Cap:28.14M

PE:-2.26

High:0.028

Open:0.027

Low:0.027

Close:0.027

Loading ...

Overview Company News Filings

Neurotech bounces back from FDA rejection with new NTI164 baseline study

The Market Herald

Neurotech International Ltd-Nti Receives Ethics Approval to Commence Human Pk Study

THOMSON REUTERS

Why Neurotech International Limited (ASX:NTI) Could Be Worth Watching

Simply Wall St.

ASX Market Open: Australia stocks track higher despite sluggish US performances after Fed comments | November 15, 2024

The Market Herald

BRIEF-Neurotech Appoints Anthony Filippis As CEO

ASX Small-Cap Stocks to Watch

MT Newswires Live

ASX Alert-Neurotech Appoints DR Anthony Filippis as Md/CEO-Nti.ax

THOMSON REUTERS

Neurotech International Ltd - Appointment of DR Anthony Filippis as Managing Director and CEO

THOMSON REUTERS

ASX Market Close: Oil price jumps but miners drag | October 4, 2024

The Market Herald

BUZZ-Australia's Neurotech falls on drug request denial by U.S. FDA

BRIEF-Neurotech International Says U.S. FDA Declined Request For Orphan Drug Designation

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

The Market Herald

Neurotech International - Request for Orphan Drug Designation With US FDA for Nti164 in Children & Adults With Pandas/Pans Has Been Declined

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NTI.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NTI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","market":"AU","secType":"STK","nameCN":"NEUROTECH INTERNATIONAL LTD","latestPrice":0.027,"timestamp":1745302320000,"preClose":0.027,"halted":0,"volume":1601788,"delay":0,"nameEN":"NEUROTECH INTERNATIONAL LTD","floatShares":760583617,"shares":1042121921,"eps":-0.011964,"marketStatus":"Closed","change":0,"latestTime":"04-22 16:12:00 AEST","open":0.027,"high":0.028,"low":0.027,"amount":44278,"amplitude":0.037037,"askPrice":0.028,"askSize":150000,"bidPrice":0.026,"bidSize":579606,"shortable":3,"etf":0,"ttmEps":-0.011964,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.027,"openAndCloseTimeList":[[1745280000000,1745301600000]],"volumeRatio":3.56674,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NTI.AU\",,,,,undefined,":{"symbol":"NTI.AU","floatShares":760583617,"roa":"-129.79%","roe":"-223.80%","lyrEps":-0.005558,"volumeRatio":3.56674,"shares":1042121921,"dividePrice":0,"high":0.028,"amplitude":0.037037,"preClose":0.027,"low":0.027,"week52Low":0.026,"pbRate":"4.90","psRate":"349.64","week52High":0.1,"institutionHeld":0,"latestPrice":0.027,"committee":0.588819,"eps":-0.011964,"divideRate":0,"volume":1601788,"delay":0,"ttmEps":-0.011964,"open":0.027,"prevYearClose":0.055,"prevWeekClose":0.027,"prevMonthClose":0.033,"prevQuarterClose":0.033,"fiveDayClose":0.03,"twentyDayClose":0.037,"sixtyDayClose":0.047},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NTI.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2486488407","title":"Neurotech bounces back from FDA rejection with new NTI164 baseline study","url":"https://stock-news.laohu8.com/highlight/detail?id=2486488407","media":"The Market Herald","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486488407?lang=en_us&edition=fundamental","pubTime":"2024-11-25 07:37","pubTimestamp":1732491420,"startTime":"0","endTime":"0","summary":"Neurotech  has bounced back from a recent fast-track status rejection from the FDA, now launching a NTI164 baseline data study.On October 4, Neurotech flagged to the market the US regulator FDA had knocked back its application for orphan drug status, effectively a fast-track proviso.Orphan drug status is awarded to those compounds seeking to treat rare conditions where few if any treatments are already extant. Tax credits and reduced overall fees are benefits of winning the status, as well as marketing exclusivity rights.But the FDA in October failed to consider as rare enough Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections  and Paediatric Acute- Onset Neuropsychiatric Syndrome  respectively – the two drugs NTI164 is intended to treat.“Although we have demonstrated long term safety and efficacy of NTI164 in paediatric patients across three separate neurological disorders, a PK study is a requirement for global health regulators, including the U","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/neurotech-bounces-back-from-fda-rejection-with-new-baseline-study-for-nti164-2024-11-25/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7095","BK4218","BK7007","NTI.AU","PK","IND.AU","BK4181"],"gpt_icon":0},{"id":"2486711596","title":"Neurotech International Ltd-Nti Receives Ethics Approval to Commence Human Pk Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2486711596","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486711596?lang=en_us&edition=fundamental","pubTime":"2024-11-25 05:11","pubTimestamp":1732482695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241124:nTUE3K9CMQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTI.AU","BK7007"],"gpt_icon":0},{"id":"2484133039","title":"Why Neurotech International Limited (ASX:NTI) Could Be Worth Watching","url":"https://stock-news.laohu8.com/highlight/detail?id=2484133039","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484133039?lang=en_us&edition=fundamental","pubTime":"2024-11-20 07:01","pubTimestamp":1732057307,"startTime":"0","endTime":"0","summary":"Neurotech International Limited ( ASX:NTI ), is not the largest company out there, but it saw a significant share price...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-nti/neurotech-international-shares/news/why-neurotech-international-limited-asxnti-could-be-worth-wa","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NTI.AU","BK7007"],"gpt_icon":0},{"id":"2483652359","title":"ASX Market Open: Australia stocks track higher despite sluggish US performances after Fed comments | November 15, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2483652359","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483652359?lang=en_us&edition=fundamental","pubTime":"2024-11-15 06:16","pubTimestamp":1731622560,"startTime":"0","endTime":"0","summary":"The ASX200 is set to open 0.44% higher today, despite weak performances on Wall Street after US Federal Reserve Chair Jerome Powell suggested rates would not be cut anytime soon.On the ASX, Auric Mining Ltd  has reported an assay grading more than 10 grams per tonne from reverse circulation drilling at the Fugitive prospect, as part of a program targeting this and also the Anomaly 37 prospect – both part of its Spargoville Gold Project in Western Australia.And Neurotech International Ltd  said patients taking part in clinical trials for its cannabinoid drug therapy NTI164 to treat Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections  and Paediatric Acute-Onset Neuropsychiatric Syndrome  showed a reversal of immune system dysregulation.Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-open-australia-stocks-track-higher-despite-sluggish-us-performances-after-fed-comments-november-15-2024-2024-11-15/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7007","XAO.AU","XKO.AU","NTI.AU","XJO.AU"],"gpt_icon":0},{"id":"2482213532","title":"BRIEF-Neurotech Appoints Anthony Filippis As CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2482213532","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482213532?lang=en_us&edition=fundamental","pubTime":"2024-11-11 14:06","pubTimestamp":1731305202,"startTime":"0","endTime":"0","summary":"BRIEF-Neurotech Appoints Anthony Filippis As CEONov 11 (Reuters) - Neurotech International Ltd NTI.AX:NEUROTECH APPOINTS DR ANTHONY FILIPPIS AS MD/CEOAPPOINTMENT OF DR ANTHONY FILIPPIS AS MANAGING DIR","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241111:nFWN3MH00J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","NTI.AU"],"gpt_icon":0},{"id":"2482752215","title":"ASX Small-Cap Stocks to Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2482752215","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482752215?lang=en_us&edition=fundamental","pubTime":"2024-11-11 07:46","pubTimestamp":1731282404,"startTime":"0","endTime":"0","summary":"Investors are likely to keep an eye on the following small-cap stocks listed on the Australian Securities Exchange.Indiana Resources (ASX:IDA)Indiana Resources will make an initial dividend payment in","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7007","ECS.AU","MM8.AU","BK7142","XJO.AU","XKO.AU","BK7104","XAO.AU","FZR.AU","BK7095","BK7502","IDA.AU","NTI.AU","BK7096"],"gpt_icon":0},{"id":"2482429201","title":"ASX Alert-Neurotech Appoints DR Anthony Filippis as Md/CEO-Nti.ax","url":"https://stock-news.laohu8.com/highlight/detail?id=2482429201","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482429201?lang=en_us&edition=fundamental","pubTime":"2024-11-11 05:27","pubTimestamp":1731274055,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241110:nFWN3MH00J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","NTI.AU"],"gpt_icon":0},{"id":"2482011292","title":"Neurotech International Ltd -  Appointment of DR Anthony Filippis as Managing Director and CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2482011292","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482011292?lang=en_us&edition=fundamental","pubTime":"2024-11-11 05:27","pubTimestamp":1731274055,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241110:nFWN3MH00J:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NTI.AU","BK7007"],"gpt_icon":0},{"id":"2472829789","title":"ASX Market Close: Oil price jumps but miners drag | October 4, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2472829789","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472829789?lang=en_us&edition=fundamental","pubTime":"2024-10-04 15:17","pubTimestamp":1728026220,"startTime":"0","endTime":"0","summary":"The ASX200 has closed 0.67% lower at 8,150 points.Investors have rising concerns about the Middle Eastern conflict and are responding by exiting equities perceived to pose risk.To the sectors, Energy was the strongest performer, up 1.84%, followed by Health Care, up 0.11%. Materials was the biggest loser, down 1.18%, followed by IT, down 1.16% and Financials, down 1%.Strike Energy  finished up 9.52% on the back of surging oil prices caused by escalating Middle Eastern conflicts. Strike has multiple oil and gas development projects in Australia; its flagship project seeks to put the Perth Basin on the map.Insignia Financial  has closed up more than 2.28% after settling a class action with some members of the OnePath Master Fund and Retirement Portfolio Service.Casino gaming company Light & Wonder  closed up 7.8% after an update on the Dragon Train litigation. Aristocrat Leisure  recently secured an injunction against this game, preventing its sale and operation. Light and Wonder are now","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-oil-price-jumps-but-miners-drag-october-4-2024-2024-10-04/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7095","BK7142","ALL.AU","BK7007","BK7110","CSC.AU","BK7078","STX.AU","RIM.AU","IFL.AU","BK7062","LNW.AU","NTI.AU"],"gpt_icon":0},{"id":"2472867274","title":"BUZZ-Australia's Neurotech falls on drug request denial by U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2472867274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472867274?lang=en_us&edition=fundamental","pubTime":"2024-10-04 09:29","pubTimestamp":1728005361,"startTime":"0","endTime":"0","summary":"** Shares of Neurotech International    fall as much as 17.2% to A$0.048, set to lose most since May 26, 2023 - if current trends hold   ** The biopharmaceutical development firm says the US Food and Drug Administration  denied request for use of co's medicine in children and adults   ** Stock hits its lowest level since Aug. 30, 2023   ** 1.9 mln shares change hands, compared with the 30-day average volume of 846,268   ** Stock has lost over 13% so far this week   ** Stock is down 26% YTD as of 0121 GMT ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTI.AU","BK7007"],"gpt_icon":0},{"id":"2472722206","title":"BRIEF-Neurotech International Says U.S. FDA Declined Request For Orphan Drug Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2472722206","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472722206?lang=en_us&edition=fundamental","pubTime":"2024-10-04 09:26","pubTimestamp":1728005188,"startTime":"0","endTime":"0","summary":"Oct 4 (Reuters) - Neurotech International Ltd   :   * REQUEST FOR ORPHAN DRUG DESIGNATION WITH US FDA FOR NTI164 IN CHILDREN & ADULTS WITH PANDAS/PANS HAS BEEN DECLINED Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NTI.AU","BK7007"],"gpt_icon":0},{"id":"2472729386","title":"Neurotech knocked back by FDA as agency declares target condition not rare enough for special status","url":"https://stock-news.laohu8.com/highlight/detail?id=2472729386","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472729386?lang=en_us&edition=fundamental","pubTime":"2024-10-04 07:57","pubTimestamp":1727999820,"startTime":"0","endTime":"0","summary":"Neurotech International  has flagged to its shareholders that the FDA hasn’t granted its product NTI164 orphan drug status.Orphan drug status is that classification awarded to drugs by the FDA for, often, rare diseases. Companies can access tax credits for running trials, see less fees overall, and in some cases, the FDA will award market exclusivity for seven years.However, on Friday, Neurotech confirmed the FDA has failed to deem the company’s target conditions – Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections  and Paediatric Acute- Onset Neuropsychiatric Syndrome  respectively – as being rare enough.PANDAS is, for its part, what it sounds like – often referring to the development of obsessive compulsive tic symptoms following an infection of strep throat. The condition is regarded as an autoimmune issue.The US-based National Institute of Mental Health  writes on its webpage for the condition that certain natural antibodies a human being prod","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/neurotech-knocked-back-by-fda-as-agency-declares-target-condition-not-rare-enough-for-special-status-2024-10-04/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7007","NTI.AU"],"gpt_icon":0},{"id":"2472678272","title":"Neurotech International - Request for Orphan Drug Designation With US FDA for Nti164 in Children & Adults With Pandas/Pans Has Been Declined","url":"https://stock-news.laohu8.com/highlight/detail?id=2472678272","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472678272?lang=en_us&edition=fundamental","pubTime":"2024-10-04 06:54","pubTimestamp":1727996044,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241003:nFWN3LF191:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","NTI.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":33,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NTI.AU\",params:#limit:5,,,undefined,":[{"date":"2023-10-27","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1698361200000,"name":null,"time":"","dateTimestamp":1698325200000,"actualEps":null},{"date":"2023-07-26","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1690329600000,"name":null,"time":"","dateTimestamp":1690293600000,"actualEps":null},{"market":"AU","date":"2023-04-27","symbol":"NTI.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1682517600000,"reportTimeType":"","actualEps":null},{"date":"2023-01-30","symbol":"NTI.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1675033200000,"name":null,"time":"","dateTimestamp":1674997200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NTI.AU\",market:\"AU\",,,undefined,":[]}}